ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 601814RE

FDA Device Recall #Z-1492-2023 — Class I — March 24, 2023

Recall Summary

Recall Number Z-1492-2023
Classification Class I — Serious risk
Date Initiated March 24, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cordis US Corp
Location Miami Lakes, FL
Product Type Devices
Quantity 1058 units

Product Description

ANGIOGUARD RX / XP Emboli Capture Guidewire System, REF 601814RE

Reason for Recall

There is a potential for separation of the ANGIOGUARD RX / XP delivery system and capture sheath which include but are not limited to situations of an intra-procedural delay, unplanned percutaneous or surgical intervention, or stroke; while a replacement device is prepared.

Distribution Pattern

Worldwide distribution.

Lot / Code Information

UDI/DI 20705032056714; Lot Numbers: 35264218, 35264224, 35264806, 35265342, 35265343, 35265382, 35265383, 35265646, 35265656, 35265658, 35264206, 35265645, 35265653

Other Recalls from Cordis US Corp

Recall # Classification Product Date
Z-1511-2025 Class II Cordis, REF: C09060ML, Smart Control Vascular S... Mar 4, 2025
Z-1510-2025 Class II Cordis, REF C10040ML, Smart Control Vascular St... Mar 4, 2025
Z-1330-2025 Class II Vista Brite Tip, Judkins Right 4, REF SM7504, J... Feb 7, 2025
Z-0675-2024 Class II MYNXGRIP 6F/7F, REF MX6721, Vascular Closure De... Nov 28, 2023
Z-0674-2024 Class II MYNXGRIP 5F, REF MX5021, Vascular Closure Devic... Nov 28, 2023

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.